דיכאון עמיד העתק

דיכאון עמיד לטיפול (TRD) מוגדר לרוב ככישלון בהשגת תגובה מספקת או הפוגה בסימפטומים לאחר שימוש בשתי תרופות נוגדות דיכאון במינון מספק ולמשך זמן מספק.17 לרוע המזל, כשליש מחולי הדיכאון הם עמידים לטיפול על פי הגדרה זו.18

מספר טכניקות טיפוליות הוצעו במקרים של חוסר תגובה מספקת לטיפול בדיכאון

undefined component is not yet defined.

טיפולים מתקדמים בדיכאון
בני משפחה
מהו דיכאון
  1. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J. Multiple recurrences of major depressive disorder. American Journal of Psychiatry. 2000;157:229–233.
  2. Lopez AD, Mathers CD, Ezzati M, Jamiso DT, Murray CJL. Global Burden of Disease and Risk Factors. Oxford University Press and The World Bank; New York: 2006.
  3. Whiteford HA., Degenhardt L., Rehm J., et al Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–1586
  4. Kessler RC. The costs of depression. Psychiatr Clin North Am. 2012;35(1):1-14.
  5. Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. JAMA Psychiatry. 2018;75(4):336-346
  6. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; Washington, DC: 2013.
  7. Ostergaard SD, Jensen SOW, Bech P. The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatrica Scandinavica. 2011;124:495–496.
  8. Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nat Rev Dis Primers. 2016 Sep 15;2:16065.
  9. Fried EI, Nesse RM, Zivin K, Guille C, Sen S. Depression is more than the sum score of its parts: individual DSM symptoms have different risk factors. Psychol Med. 2014;44(10):2067-2076.

  10. Repetti RL, Taylor SE, Seeman TE. Risky families: family social environments and the mental and physical health of offspring. Psychol Bull 2002; 128: 330–366.

  11. Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry2006; 163: 109–114.

  12. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry157: 1552–1562.

  13. SalminenJK,Karlsson H,HietalaJ,KajanderJ,AaltoS,Markkula J,et al.Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.Psychother Psychosom.2008;77:351-7.

  14. Qaseem A, Barry MJ, Kansagara D; Clinical Guidelines Committee of the American College of Physicians. Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016 Mar 1;164(5):350-9.
  15. Gartlehner G, Wagner G, Matyas N, et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open. 2017;7(6):e014912. Published 2017 Jun 14. doi:10.1136/bmjopen-2016-014912